Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a minor backend/content-management update without altering the study’s content.
    Difference
    0.1%
    Check dated 2026-08-08T15:33:09.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page footer revision label changed from v3.6.3 to v3.6.4, signaling a minor content update to the Study Details page. It does not affect the study information or how the page functions.
    Difference
    0.1%
    Check dated 2026-07-25T10:26:57.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision banner updated from v3.6.2 to v3.6.3, indicating a minor internal update to the study page. It does not modify any study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-03T22:09:32.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.2 on the page, representing a small software revision.
    Difference
    0.1%
    Check dated 2026-06-26T23:53:29.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Enrollment is no longer open to participants, and the page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the page revision to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:40:38.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor backend/template update. No study details, eligibility criteria, or locations were changed.
    Difference
    0.1%
    Check dated 2026-06-05T13:11:16.000Z thumbnail image

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.